Top 50 Medical Device VC Funds & Investors in United Kingdom (May 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Parkwalk Advisors
VC Fund
|
16 | United Kingdom, United States, Philippines | Seed, Series A, Series B | Biotechnology, Health Care, Software | $860k–$33M |
|
Mercia Fund Managers
VC Fund
|
14 | United Kingdom, United States, Hungary | Seed, Series A | Software, Health Care, Biotechnology | $184k–$21M |
|
Newable Private Investing
VC Fund
|
12 | United Kingdom, United States | Seed, Series A | Software, Health Care, Biotechnology | $184k–$3.8M |
|
Archangels
VC Fund
|
11 | United Kingdom, United States | Seed, Series A | Software, Biotechnology, Health Care | $123k–$7M |
|
UK Innovation & Science Seed Fund
VC Fund
|
11 | United Kingdom, United States | Seed, Series A | Biotechnology, Health Care, Medical | $246k–$10M |
|
SyndicateRoom
VC Fund
|
10 | United Kingdom, United States, India | Seed, Equity Crowdfunding | Health Care, Software, Medical | $229k–$1.8M |
|
Scottish Investment Bank
VC Fund
|
10 | United Kingdom, United States, France | Seed, Series A | Software, Biotechnology, Information Technology | $307k–$7.6M |
|
Kelvin Capital
VC Fund
|
9 | United Kingdom, United States | Seed, Series A | Health Care, Biotechnology, Manufacturing | $139k–$24M |
|
Oxford Technology Management
VC Fund
|
9 | United Kingdom, United States | Seed, Series A | Biotechnology, Health Care, Software | $25k–$7.4M |
|
Scottish Enterprise
VC Fund
|
9 | United Kingdom, United States, Japan | Grant, Seed | Biotechnology, Software, Health Care | $92k–$4.1M |
|
Deepbridge Capital
VC Fund
|
9 | United Kingdom, Australia, Singapore | Seed, Series A | Health Care, Biotechnology, Medical | $143k–$10M |
|
Longwall Venture
VC Fund
|
8 | United Kingdom, Germany, Philippines | Seed, Series A | Biotechnology, Medical Device, Health Care | $283k–$16M |
|
Catapult Ventures
VC Fund
|
8 | United Kingdom, United States, Israel | Seed, Series A | Health Care, Biotechnology, Pharmaceutical | $123k–$26M |
|
Northstar Ventures
VC Fund
|
7 | United Kingdom, United States, Estonia | Seed, Series A | Software, E-Commerce, Internet | $37k–$8.8M |
|
Development Bank of Wales
VC Fund
|
7 | United Kingdom, Australia, United States | Seed, Debt Financing | Health Care, Software, Biotechnology | $12k–$2.8M |
|
Techstart Ventures
VC Fund
|
7 | United Kingdom, Ireland | Seed, Pre-Seed | Software, Health Care, Information Technology | $86k–$2.5M |
|
Innovate UK
VC Fund
|
6 | United Kingdom, United States, Singapore | Grant, Seed, Pre-Seed | Health Care, Software, Biotechnology | $61k–$3.4M |
|
Nesta Ventures
VC Fund
|
6 | United Kingdom, United States | Seed, Series A | Biotechnology, Medical Device, Medical | $922k–$26M |
|
IP Group
VC Fund
|
6 | United Kingdom, United States, Australia | Seed, Series A, Series B | Health Care, Biotechnology, Therapeutics | $369k–$61M |
|
SFC Capital
VC Fund
|
5 | United Kingdom, United States, Canada | Pre-Seed, Seed | Software, Information Technology, Artificial Intelligence | $123k–$2M |
|
Midven
VC Fund
|
5 | United Kingdom, United States, Israel | Seed, Series A | Software, Manufacturing, Information Technology | $123k–$1.8M |
|
Oxford Investment Consultants LLP
VC Fund
|
5 | United Kingdom | Series A, Seed | Health Care, Software, Biotechnology | $922k–$21M |
|
Angels in MedCity
VC Fund
|
5 | United Kingdom, United States | Seed, Angel | Health Care, Biotechnology, Medical | $614k–$774k |
|
TRICAPITAL
VC Fund
|
5 | United Kingdom, France | Seed, Series B | Biotechnology, Software, Health Care | $172k–$6.4M |
|
Clarendon Fund Managers
VC Fund
|
5 | United Kingdom, United States, Ireland | Seed, Series A | Software, Health Care, Security | $307k–$2.9M |
|
Barwell Plc
VC Fund
|
4 | United Kingdom | Series B, Series A | Software, Health Care, Biotechnology | |
|
Tern
VC Fund
|
4 | United Kingdom, United States | Seed, Series A | Software, Information Technology, Artificial Intelligence | $1.1M–$1.4M |
|
The North West Fund
VC Fund
|
4 | United Kingdom, United States | Seed, Series A, Series B | Health Care, Medical Device, Biotechnology | $123k–$3.8M |
|
Midlands Engine Investment Fund
VC Fund
|
4 | United Kingdom, United States, Thailand | Debt Financing, Seed | Health Care, Manufacturing, Software | $246k–$1.8M |
|
Octopus Ventures
VC Fund
|
4 | United Kingdom, United States, Germany | Series A, Seed, Series B | Software, Health Care, FinTech | $1.2M–$45M |
|
Business Growth Fund
VC Fund
|
4 | United Kingdom, Ireland, United States | Series A, Private Equity | Software, Information Technology, Manufacturing | $1.2M–$28M |
|
Mercia Asset Management PLC
VC Fund
|
4 | United Kingdom, United States | Series A, Seed | Software, Information Technology, Manufacturing | $369k–$11M |
|
VentureFounders
VC Fund
|
4 | United Kingdom, United States | Series A, Seed | Health Care, Software, Medical | $522k–$6.1M |
|
Oxford Science Enterprises
VC Fund
|
4 | United Kingdom, United States, The Netherlands | Seed, Series A | Biotechnology, Health Care, Software | $1M–$34M |
|
Angels 5K
VC Fund
|
4 | United Kingdom | Seed, Angel | Biotechnology, Software, Medical | $74k–$1.2M |
|
The FSE Group
VC Fund
|
4 | United Kingdom, United States, Canada | Debt Financing, Seed | Software, Information Technology, Manufacturing | $61k–$1.8M |
|
Antler
VC Fund
|
3 | Singapore, United Kingdom, Australia | Pre-Seed, Seed, Series A | Software, Information Technology, SaaS | $100k–$29M |
|
EMV Capital
VC Fund
|
3 | United Kingdom, United States, Israel | Seed, Series A | Health Care, Medical, Manufacturing | $614k–$5M |
|
Novartis Venture Fund
VC Fund
|
3 | United States, Switzerland, United Kingdom | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics | $4.8M–$80M |
|
Invesco
VC Fund
|
3 | United States, United Kingdom, China | Series B, Series C | Biotechnology, Health Care, Software | $3M–$195M |
|
Oxford Capital
VC Fund
|
3 | United Kingdom, United States, France | Seed, Series A | Software, Mobile, Health Care | $1.6M–$13M |
|
SR One
VC Fund
|
3 | United States, United Kingdom, Canada | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $3.7M–$85M |
|
NPIF – Mercia Equity Finance
VC Fund
|
3 | United Kingdom | Seed, Series A | Software, Information Technology, Health Care | $307k–$6.1M |
|
Par Equity
VC Fund
|
3 | United Kingdom, United States, Brazil | Seed, Series A | Software, Information Technology, Computer | $244k–$7.9M |
|
Mercia Asset Management
VC Fund
|
3 | United Kingdom, United States | Seed, Series A | Health Care, Software, SaaS | $823k–$2.9M |
|
Equity Gap
VC Fund
|
3 | United Kingdom | Seed, Series A | Information Technology, Software, SaaS | $307k–$9.2M |
|
Wren Capital
VC Fund
|
3 | United Kingdom | Seed, Series A | Biotechnology, Health Care, Software | $1.5M–$19M |
|
Wealth Club
VC Fund
|
3 | United Kingdom, United States | Seed, Series A | Health Care, Medical, Medical Device | $1.2M–$5.5M |
|
Cambridge Angels group
VC Fund
|
3 | United Kingdom, United States, Estonia | Seed, Series A | Software, Health Care, Biotechnology | $244k–$16M |
|
GM&C Life Sciences Fund
VC Fund
|
3 | United Kingdom, Italy, Germany | Seed, Series A | Health Care, Biotechnology, Medical | $61k–$903k |
| Access all 472 VC funds in United Kingdom Medical Device startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Parkwalk is a London-based fund management firm. Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009,anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth.Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Philippines
Investor stats
- Total investments: 211
- Round size: Seed $860k–$3.7M; Series A $1.5M–$12M; Series B $1.8M–$33M
- Lead/follow: 26% lead, 74% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- RoboK — A Cambridge University spin-out building cost-effective 3D sensing software technology
- Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
- PharmEnable — Designing the next generation of small molecule drugs. Replicating the specificity of biologics in the scalable form of a small molecule.
Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A
- Geography: United Kingdom, United States, Hungary
Investor stats
- Total investments: 119
- Round size: Seed $184k–$1.8M; Series A $1.2M–$21M
- Lead/follow: 69% lead, 31% follow
- Last fund: May invest from a new fund soon — last raise in 2013
Portfolio highlights
- CanSense — CanSense is a developer of an inexpensive and scalable blood test intended for early diagnosis of bowel cancer.
- Workbuzz — Issue employee engagement surveys with WorkBuzz - a fast, simple, and flexible platform with expert consultancy. Try it now!
- Centuro Global — Centuro Global helps you go global.We help startups, scaleups & corporates enter new markets around the world. All your international expansion needs are serviced from one platform, whether you need legal support, tax & accounting, HR, opening a bank account or finding office space, we can assist across the board.Our innovativeplatform, Centuro Connect, contains blueprints on how to do business in over 150 countries, provides live chat advice, and access to local experts around the world. Instead of losing time undertaking Google searches for relevant information and identifying trusted, cost-effective service providers, find all your solutions through Centuro Connect.Come to us for services including; Legal, Immigration, Intellectual Property, Scaling & Expansion, New Market Entry, Tax & Accounting and much more.Receive advice, find service providers, investors and like minded individuals, and seamlessly grow your business.Book a free consultation with us: www.centuroglobal.com
Newable helps businesses thrive through funding, professional support and premises. Unleashing potential, building resilience & championing growth.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 100
- Round size: Seed $184k–$2.9M; Series A $1.2M–$3.8M
- Lead/follow: 23% lead, 77% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Delta g — Delta g Limited is a quantum technology and gravity gradiometry company. A spin-out from the University of Birmingham our technology has applications in industries as varied as civil engineering, infrastructure, defence, rail, navigation and resource exploration. Experts from science, engineering an
- EarSwitch — Empowering new ways to control and connect with the world through in-ear biometric switch and sensor technology
- RAB Microfluidics — We diagnose early signs of failure in lubricated machinery and prevent equipment failure using our patented microfluidic technology and AI technology.
Established in 1992. Archangels is the oldest continuously operating business angel syndicate in the World. Investing in IP-rich tech & life sciences companies in Scotland, UK.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 72
- Round size: Seed $123k–$2.7M; Series A $1.5M–$7M
- Lead/follow: 54% lead, 46% follow
Portfolio highlights
- Bio-Images Drug Delivery — BDD Pharma combine drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and new innovative pharmaceutical products. Rapid parallel clinical testing with SWIFT significantly reduces time from product concept to clinical success.
- Cytomos — Cytomos develops and provides integrated, predictive analytics systems for intelligent bioprocessing in biopharma and cell therapy domains.
- Administrate — Manage 100% of enterprise training operations with configurable training management software, designed to scale with your organization.
UKI2S, formally the Rainbow Seed Fund, is an investment fund backed by the government, providing seed funding to science & technology start-ups and SMEs
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 96
- Round size: Seed $246k–$2.9M; Series A $2.7M–$10M
- Lead/follow: 32% lead, 68% follow
- Last fund: May invest from a new fund soon — last raise in 2014
Portfolio highlights
- Machine Discovery — Machine Discovery is a University of Oxford spin-out commercializing new machine learning technology. We leverage proprietary neural network technology to accelerate expensive calculations — and we do it with minimal data and 99.9% fidelity.
- Pencil Biosciences — Next Generation Genome Editing Tool
- Laverock Therapeutics — Laverock Therapeutics is developing a gene silencing platform for the creation of programmable, allogeneic cell therapies.
SyndicateRoom is fintech company made up of data-scientists, investment professionals, software developers and marketers with one mission: to be an early investor in every British startup success story.To do this – and make fund investors money – we don’t try to spot the next Big Thing.Instead, we apply a data-driven model to portfolioconstruction; a repeatable process designed to maximise returns and minimise risk for fund investors. As such, we build startup portfolios that don’t attempt to predict the future; they work to stack the odds in investors’ favour.Our fund, Access EIS, aims to build investors a diversified portfolio of 50+ companies by co‑investing exclusively with some of the UK’s best-performing angel investors.
Show more...Investment focus
- Industry: Health Care, Software, Medical
- Stage:Seed, Equity Crowdfunding
- Geography: United Kingdom, United States, India
Investor stats
- Total investments: 109
- Round size: Seed $240k–$1.8M; Equity Crowdfunding $229k–$1.5M
- Lead/follow: 10% lead, 90% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Connectd — Online platform underpinned by smart matching technology directly connecting the UK’s leading Founders, Investors & NAMs.
- Five Alarm Bio — Five Alarm Bio is a drug discovery company. Five Alarm intends to use discoveries to provide secure and efficient remedies for a variety of age-related illnesses and limitations. Five Alarm Bio is creating a small molecule strategy to strengthen the body's defense against aging.
- Pencil Biosciences — Next Generation Genome Editing Tool
Our Entrepreneurship team (formerly the Scottish Investment Bank) helps you find sources of finance, engage with funders and secure investment to grow your business.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Series A
- Geography: United Kingdom, United States, France
Investor stats
- Total investments: 195
- Round size: Seed $307k–$2.5M; Series A $1.5M–$7.6M
- Lead/follow: 10% lead, 90% follow
- Last fund: May invest from a new fund soon — last raise in 2015
Portfolio highlights
- Bio-Images Drug Delivery — BDD Pharma combine drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and new innovative pharmaceutical products. Rapid parallel clinical testing with SWIFT significantly reduces time from product concept to clinical success.
- IOTech — Discover IOTech Systems, the open edge data platform for developing, deploying, and managing Industrial Edge applications at scale. Find out more here.
- Administrate — Manage 100% of enterprise training operations with configurable training management software, designed to scale with your organization.
We invest venture capital in to globally ambitious companies which have the potential to deliver a significant return to our investors
Show more...Investment focus
- Industry: Health Care, Biotechnology, Manufacturing
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 72
- Round size: Seed $139k–$1.1M; Series A $1.6M–$24M
- Lead/follow: 49% lead, 51% follow
Portfolio highlights
- novosound — Novosound is an award winning Scottish sensors company utilising thin-film processes to eliminate conventional limitations in ultrasound sensors.
- Snappy Shopper — Order your favourite products from your local convenience store, for delivery from as little as 30 minutes with Snappy Shopper. Your every day essentials are only a click away - order your grocery delivery online or through our app.
- Sofant Technologies — Sofant is developing a low cost RF MEMS technology that solves power consumption and heat problems in high frequency phased array antenna systems.
Oxford Technology's SEIS fund and EIS fund enable private investors to access high growth technology startup opportunities and support UK innovation. SEIS and EIS tax reliefs offer downside protection, whilst gains can be tax free.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 104
- Round size: Seed $25k–$2M; Series A $737k–$7.4M
- Lead/follow: 7% lead, 93% follow
- Last fund: May invest from a new fund soon — last raise in 2012
Portfolio highlights
- OxCan — Enabling curative cancer treatment through early detection
- Machine Discovery — Machine Discovery is a University of Oxford spin-out commercializing new machine learning technology. We leverage proprietary neural network technology to accelerate expensive calculations — and we do it with minimal data and 99.9% fidelity.
- MitoRx Therapeutics — Developing revolutionary mitochondrial-protective therapeutics which reverse mitochondrial dysfunction to arrest decline in muscular dystrophy and neurodegeneration. MitoRx Therapeutics' first-in-class first-in-target platform has potential to arrest the progression of some of the most challenging diseases.
Scotland's business advice, support and funding agency. Explore our products and services to find the right support for your business and apply online today.
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Grant, Seed
- Geography: United Kingdom, United States, Japan
Investor stats
- Total investments: 193
- Round size: Seed $197k–$2.9M; Grant $92k–$4.1M
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- Pneumagen — Pneumagen focuses on developing glycan targeted carbohydrate-binding modules (CBMs) as a new universal therapeutic modality for the treatment of respiratory tract infections (RTIs) and cancer. Founded in 2016, the Company is a spin-out from the University of St Andrews in Scotland and has access to world-class scientific expertise and capabilitiesin glycobiology.
- Microplate Dx — Microplate Dx is a developer of diagnostic technology aimed at significantly reducing fatalities caused by drug-resistant infections.Microplate Dx, an award-winning spinout company from the University of Strathclyde in Glasgow, focuses on creating innovative diagnostic solutions to combat the significant global health challenge of antimicrobialresistance. Their technology revolves around the ingenious concept of employing highly sensitive biosensor electrodes, enhanced with miniaturized hydrogel deposits containing various antibiotics tailored to the specific infection being detected. The primary mission of Microplate DX is to proactively prevent and manage the proliferation of antimicrobial resistance on a global scale.
- Rapscallion Soda — Award Winning, Fresh Fruit, Low Calorie Soft Drinks, Handmade in Scotland. Fresh batches made weekly. Free UK Mainland Delivery. International Shipping. Ginga Ninja | Burnt Lemon | Dry Lime | Scottish Rhubarb Soda | Scottish Strawberry Soda | Cranachan Soda | Blueberry Soda Love soda. Hate hangovers. Drink local.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Deepbridge is a different kind of investment manager. They work closely with financial advisers and investors to design innovative products, ranging from investment in technology growth companies to asset-backed renewable energy projects. They also partner with innovative and committed management teams to help UK based companies realise theirpotential and become successful leading-edge businesses.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: United Kingdom, Australia, Singapore
Investor stats
- Total investments: 77
- Round size: Seed $143k–$2.1M; Series A $1.8M–$10M
- Lead/follow: 78% lead, 22% follow
- Last fund: Likely still investing — raised $1.2M in 2022
Portfolio highlights
- Circada — Innovative Circadian lighting reconnects the body clock with nature
- Microplate Dx — Microplate Dx is a developer of diagnostic technology aimed at significantly reducing fatalities caused by drug-resistant infections.Microplate Dx, an award-winning spinout company from the University of Strathclyde in Glasgow, focuses on creating innovative diagnostic solutions to combat the significant global health challenge of antimicrobialresistance. Their technology revolves around the ingenious concept of employing highly sensitive biosensor electrodes, enhanced with miniaturized hydrogel deposits containing various antibiotics tailored to the specific infection being detected. The primary mission of Microplate DX is to proactively prevent and manage the proliferation of antimicrobial resistance on a global scale.
- GenoMe Diagnostics — GenoME Diagnostics - We are developing a blood test for an earlier and more accurate diagnosis of ovarian cancer.GenoME Diagnostics .
Longwall Ventures invests in innovative, UK based, early stage companies in the healthcare, science and engineering sectors
Show more...Investment focus
- Industry: Biotechnology, Medical Device, Health Care
- Stage:Seed, Series A
- Geography: United Kingdom, Germany, Philippines
Investor stats
- Total investments: 39
- Round size: Seed $283k–$5.3M; Series A $2.1M–$16M
- Lead/follow: 36% lead, 64% follow
- Last fund: May invest from a new fund soon — raised $92M in 2017
Portfolio highlights
- Wayland Additive — Wayland Additive Limited is a West-Yorkshire based company pushing the boundaries of electron beam 3D printing. Wayland’s goal is to develop, manufacture and sell metal Additive Manufacturing (“AM” – 3D printing) machines to industrial end-users such as major players in the aerospace and medical industries.
- Caristo Diagnostics — Coronary Artery Inflammation causes heart attacks. We detect and measure coronary inflammation and plaque on CCTA with CaRi-Heart technology
- Lightcast Discovery — Flexible control over droplet number, occupancy, location and movement. Enabling efficient, multi-step workflows with unprecedented flexibility.
The team behind Catapult Ventures are among the most experienced venture capital investors in the UK.Their experience spans a range of sectors from healthcare and pharmaceuticals to luxury consumer brands, manufacturing and software, as well as all stages: from start-ups and pre-revenue IP developers to company floatation and billions of poundsin revenue. Their administration team is equally experienced with each member having more than 10 years experience in a venture capital environment.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Pharmaceutical
- Stage:Seed, Series A
- Geography: United Kingdom, United States, Israel
Investor stats
- Total investments: 96
- Round size: Seed $123k–$985k; Series A $1.6M–$26M
- Lead/follow: 26% lead, 74% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- Pickle Robot — We make robots that unload trucks without retrofitting the warehouse
- Urban Machine — Salvaging the past to build the future- Stealth Startup
- Pencil Biosciences — Next Generation Genome Editing Tool
Northstar Ventures is a venture capital firm investing in innovative solutions to help solve the most pressing societal issues we have today. Our ticket sizes range from £100k to £500k into early stage tech companies. We provide added value in leveraging our network of university partners, funders, non-executive directors and talent to supporteach investment.
Show more...Investment focus
- Industry: Software, E-Commerce, Internet
- Stage:Seed, Series A
- Geography: United Kingdom, United States, Estonia
Investor stats
- Total investments: 153
- Round size: Seed $37k–$1.2M; Series A $276k–$8.8M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- IOTech — Discover IOTech Systems, the open edge data platform for developing, deploying, and managing Industrial Edge applications at scale. Find out more here.
- MarraBio — MarraBio Ltd. is a spin out company from Newcastle University using engineered bacterial protein polymers to provide bioactivity to cells at the industrial scale in the cultivated meat sector and beyond.
- Peek Home — Peek Home provides sketch plans, prices and planning advice for people who are puzzled by the process of creating their perfect home. All we need is your house number & postcode - no home visit needed.
Development Bank of Wales is formed in 2001 by the Welsh Assembly Government. Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Seed, Debt Financing
- Geography: United Kingdom, Australia, United States
Investor stats
- Total investments: 149
- Round size: Seed $307k–$1.8M; Debt Financing $12k–$2.8M
- Lead/follow: 58% lead, 42% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- CanSense — CanSense is a developer of an inexpensive and scalable blood test intended for early diagnosis of bowel cancer.
- Stratigens — Talent intelligence software| external people analytics | Diversity, location planning and skills data to inform strategy | Data based decision making
- 2B Enterprising — 2B Enterprising offers an enterprise education program for primary schools that aims to inspire next generation and foster an entrepreneurial mindset.
Techstart Ventures is a leading investor of seed capital across Scotland and Northern Ireland. they are a trusted partner to ambitious founders on their journey to success.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Pre-Seed
- Geography: United Kingdom, Ireland
Investor stats
- Total investments: 129
- Round size: Seed $154k–$2.5M; Pre-Seed $86k–$1.5M
- Lead/follow: 48% lead, 52% follow
Portfolio highlights
- Enzai — Enzai's AI governance platform allows you to build and deploy AI with confidence. Measure your progress in AI responsibility, and get actionable steps with our 3-minute maturity assessment.
- MDD systems — MDDSystems provides high-quality consultancy and design services in Sensor measurement, Data monitoring, and recording, Wireless data transmission, Data analysis, Project Management. ,
- Continuum Industries — Continuum Industries is a developer of Optioneer, the leading software for linear infrastructure optioneering.
Innovate UK is part of the UK Research and Innovation .
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Grant, Seed, Pre-Seed
- Geography: United Kingdom, United States, Singapore
Investor stats
- Total investments: 288
- Round size: Seed $283k–$3.4M; Grant $61k–$2.5M; Pre-Seed $123k–$922k
- Lead/follow: 79% lead, 21% follow
Portfolio highlights
- FlexSea — FlexSea develops novel biomaterials derived from renewable marine resources to replace current primary plastic packaging.
- Concretene — Concretene is a concrete alternative that is designed to provide a viable CO2 reduction technology in the construction industry for cementitious products. It is developed by Nationwide Engineering Research and Development (NERD) with the Graphene Engineering Innovation Centre (GEIC).
- Pathios Therapeutics — Pioneering a novel macrophage conditioning approach to delivering breakthrough cancer therapies
We bring bold ideas to life to change the world for good.
Show more...Investment focus
- Industry: Biotechnology, Medical Device, Medical
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 72
- Round size: Seed $922k–$2.2M; Series A $1.5M–$26M
- Lead/follow: 10% lead, 90% follow
- Last fund: May invest from a new fund soon — raised $31M in 2014
Portfolio highlights
- Citymart — Citymart powers cities to deliver services that work. Following best practices developed with leading cities around the world, Citymart connects cities and revolutionizes the way cities frame needs, complete procurements, and improve service delivery. Over 100 cities in 35 countries have adopted Citymart tools and methods to-date.
- Featurespace — Featurespace™ is the world leader in Enterprise Financial Crime prevention for fraud and Anti-Money Laundering. Featurespace invented Adaptive Behavioral Analytics and Automated Deep Behavioral Networks, both of which are available through the ARIC™ platform, a real-time machine learning software that risk scores events in more than 180 countriesto prevent fraud and financial crime.ARIC™ Risk Hub uses advanced, explainable anomaly detection to enable financial institutions to automatically identify risk, catch new fraud attacks and identify suspicious activity in real-time. More than 30 major global financial institutions are using ARIC to protect their business and their customers. Publicly announced customers include HSBC, TSYS, Worldpay, NatWest, Contis, Danske Bank, ClearBank, Akbank and Permanent TSB.
- Radio Physics Solutions — Download Lagu MP3 Gratis. Download Lagu Gratis Terbaru 2023, Situs Download Lagu Mp3 Gratis, Download Lagu dari YouTube, Gudang Lagu Indonesia, Barat Terbaik, Cepat dan Mudah.
IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Therapeutics
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Australia
Investor stats
- Total investments: 157
- Round size: Seed $369k–$6.4M; Series A $1.8M–$17M; Series B $7.4M–$61M
- Lead/follow: 24% lead, 76% follow
- Last fund: May invest from a new fund soon — last raise in 2014
Portfolio highlights
- AccelerComm — Our patented, market-leading IP solutions for 4G and 5G are configurable for quick, high-performance implementations across a wide range of applications.
- Deep Render — Deep Render Ltd. is a spin-out from the Department of Computing at Imperial College London. We are a London based AI start-up that is developing the next generation of media compression algorithms. Our proprietary and patented technology is at the forefront of machine learning research. Furthermore, our Biological Image Compression results arestate-of-the-art, providing at least a 50% efficiency gain over the previous standards
- Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
SFC Capital, the UK's most active seed investor (PitchBook, 2020), provides capital and support to British startups. By combining its Angel Network and Seed Funds, SFC has created a unique model that allows investors to get exposure to SEIS- and EIS-qualifying businesses, either directly or through a diversified portfolio curated and managedby SFC’s expert team. In 2020, SFC received a £10m allocation from Business Investments as part of the Regional Angels Programme in support of SFC's mission to back promising early-stage companies from every corner of the UK.SFC Capital is an Appointed Representative of SFC Capital Partners Ltd which is authorised and regulated by the UK Financial Conduct Authority (FRN 736184).
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Pre-Seed, Seed
- Geography: United Kingdom, United States, Canada
Investor stats
- Total investments: 179
- Round size: Seed $153k–$2M; Pre-Seed $123k–$492k
- Lead/follow: 43% lead, 57% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Odore — Our platform enables the world's leading brands to sample their products more effectively.
- Decently — Decently provides the world a better place by developing advanced digital products. Decently mission is to improve lives through innovative digital product.
- TrainThis.AI — TrainThis.AI revolutionizes the way you manage and coach your team. Say goodbye to wasting hours on call reviews and email reading just to provide feedback on a fraction of the work. The company's real-time feedback system empowers your reps to receive continuous input on their work, eliminating poor-quality outcomes and maximizing thebenefits of ongoing feedback.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Midven is a specialist venture capital company providing investment to fast growing small and medium sized enterprises ("SMEs"), run by an energetic, experienced and hands-on team of investment managers.
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Seed, Series A
- Geography: United Kingdom, United States, Israel
Investor stats
- Total investments: 106
- Round size: Seed $123k–$1.2M; Series A $369k–$1.8M
- Lead/follow: 35% lead, 65% follow
- Last fund: May invest from a new fund soon — raised $43M in 2018
Portfolio highlights
- MetCloud — METCLOUD is a next generation, cyber security & cloud platform provider. Contact our team today for pioneering cyber security solutions!
- When in Rome — We bring you craft wines made by small, independent producers and sold in convenient, eco-friendly bag-in-boxes at a great price with free delivery.
- Medmin Group Limited — Medmin is building a group of healthcare businesses that will transform private medical treatment for the uninsured and the clinicians that treat them. We are developing a network of clinics across the UK, grouping clinicians together into branded, condition focussed clinics that patients can easily identify online. The clinics will provide care toour "Get Well Soon" patients and also undertake work for insured and self-pay patients requiring other procedures and treatments.
xford Investment Consultants LLP ("OIC") advises Thompson Taraz, the Investment Manager of Oxford Technology and Innovations EIS Fund ("OTIF"). OIC is an Appointed Representative of Stoneware Captial LLP, which is authorized and regulated by the Financial Conduct Authority in the United Kingdom.The focus of OIC research ison University of Oxford spin out companies.Over the last fifteen years Oxford has produced a string of world-class spin-out companies. It is our belief that the next generation of world-class Oxford businesses is just waiting to be discovered.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Series A, Seed
- Geography: United Kingdom
Investor stats
- Total investments: 23
- Round size: Seed $922k–$7.1M; Series A $11M–$21M
- Lead/follow: 9% lead, 91% follow
- Last fund: May invest from a new fund soon — last raise in 2012
Portfolio highlights
- Diffblue — Diffblue Generative AI for Code helps you shift left by autonomously writing full suites of Java unit regression tests so you can catch errors faster and earlier in your pipeline
- Living Optics — Living Optics is commercializing next generation imaging technology which leverages a compact camera system based on breakthroughs in hardware design and software processing.
- Caristo Diagnostics — Coronary Artery Inflammation causes heart attacks. We detect and measure coronary inflammation and plaque on CCTA with CaRi-Heart technology
Angels in MedCity is a partnership between MedCity, London Business Angels and Angels4LifeSciences. The programme aims to introduce new people to investing and investing in the healthcare/life sciences sector via investor workshops and introduce business angels to investment opportunities from highly-selected and trained companies.With aparticular focus on drug therapies, digital health and medical device technologies, Angels in MedCity brings potential investors together with life sciences experts in a programme aimed at both people who are new to investing and experienced investors who have little or no experience in the life sciences sector. The aim is to build investor understanding in the life sciences sector and support life sciences companies to gain funding to commercialise their ideas.Angels in MedCity has created a community of investors supported through a programme of investor workshops. Using case studies and tips from experienced investors in the field, the workshops explain how to identify and structure a good deal in the life sciences sector, as well as provide expert advice on tax breaks and legal issues.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Angel
- Geography: United Kingdom, United States
Investor stats
- Total investments: 18
- Round size: Seed $614k–$774k
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Atelerix — The Atelerix technology provides an innovative solution for storing and transporting cells and tissues at room temperature.
- Clustermarket — The intuitive lab management system for all academic research facilities and industrial laboratories that need to efficiently manage equipment bookings.
- DynamX Medical — DynamX Medical has developed a reliable and inexpensive precancer screening system for rapid tissue biopsy analysis that can be operated point-of-care by nurses.
The TRICAPITAL Syndicate is a business angel cohort of entrepreneurs, CEOs and business leaders who have founded, funded and built companies
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Seed, Series B
- Geography: United Kingdom, France
Investor stats
- Total investments: 47
- Round size: Seed $246k–$1.2M; Series B $172k–$6.4M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- ŌGI Bio — Offering an affordable route to automating routine microbial culturing with a unique, modular, retrofittable device
- Carcinotech — Carcinotech is a MedTech company manufacturing 3D printed mini tumours developed from patient-specific cancer stem cells, primary cells and established cell lines.
- Heero Technologies — Heero Technologies, the leading independent energy platform for making net zero homes a reality
Clarendon Fund Managers is a venture capital fund manager based in Belfast, focused on co-investments with business angel and private investor lead deals. It manages £42.5m of regional VC Funds in Northern Ireland including the £30m Co-Investment Fund and has invested in over 60 companies since it began investing in 2001.
Show more...Investment focus
- Industry: Software, Health Care, Security
- Stage:Seed, Series A
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 41
- Round size: Seed $307k–$2.9M; Series A $2.6M–$2.9M
- Lead/follow: 7% lead, 93% follow
- Last fund: May invest from a new fund soon — last raise in 2003
Portfolio highlights
- Angoka — ANGOKA is an IoT security company focused on protecting M2M communications for Smart Cities and Mobility. Headquartered in Belfast, with offices in London and The Hague, ANGOKA offers solutions that protect devices’ identities. With an increase of inherently insecure networks coming online with the boom of IoT, ANGOKA’s solutions safeguard criticalmachine-to-machine communication integrity and data provenance, creating trusted connections, even in untrustworthy networks.ANGOKA is the only cybersecurity company to win a place on Zenzic’s CAM Scale-Up Programme, delivered in partnership with Plug and Play. ANGOKA was also the first NI start-up to be selected for NCSC’s Cyber Accelerator, who reviewed and assessed ANGOKA’s technology. ANGOKA is also an alumnus of Seraphim Space Camp, Yes!Delft and TechNation Cyber 2.0. Finally, ANGOKA has been awarded several Innovate UK R&D projects, which focus on securing quantum communications (led by BT) and two drone projects.
- Surgery Hero — We combine expert human care, individually-tailored content and cutting edge tech to empower people to take control of their health so they can conquer their surgery.
- Rock Extraction — Rock Extraction is developing a cleantech alternative to explosives.
Barwell is a privately-funded venture capital company that is based in Glasgow, Scotland.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series B, Series A
- Geography: United Kingdom
Investor stats
- Total investments: 7
- Lead/follow: no public data
Portfolio highlights
- MGB Biopharma — MGB Biopharma Limited is a biopharmaceutical company established to develop a completely new class of anti-infective medicines based upon compounds which are DNA Minor Groove Binders (MGB)The company has an exceptionally experienced team from both pharma and biotech sectors and is dedicating its focus initially to the development of smallmolecules with specific antibacterial efffects against resistant bacteriaBy selecting a new class of antibacterial, the company believes the novel mode of action should prove to be very potent against bacteria as these target organisms will lack any inherent resistance, unlike that typically facing new drugs which are the result of modifications from existing classes of drugs used to treat bacterial infection
- Connect-In Ltd — Connect-In Ltd. stands for innovative Bluetooth IoT solutions, sustainable development, and state-of-the art design. Their sensors are built to be long lasting and power efficient (lasts 1-4 years on replaceable coin cell batteries) to make IoT understandable, accessible, and affordable, and to power the next generation of the Internet of Things.
- Lamellar Biomedical — Lamellar Biomedical Ltd was established in June 2007 when the founding Directors of the Company, recognising the considerable therapeutic potential of Lamellasomes™, acquired the intellectual property rights to the technology.
Looking for an IoT investor for your start up or early stage company? Tern PLC is a venture capitalist working alongside ambitious entrepreneurs in the Internet of Things (IoT) space to deliver strategic IoT investment to grow your company.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 20
- Round size: Seed $1.1M–$1.4M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- Konektio — With over 20+ years of industrial IoT experience - Konektio's condition-based and energy-monitoring solutions keep your machines running.
- FundamentalVR — Implement a customized, flexible, and cost-effective training solution to accelerate the rollout of your medical device, surgical robotic system, or product.
- Talking Medicines — Data tech innovator Talking Medicines, based in Glasgow and London, uses advanced AI and ML to provide pharmaceutical companies with real-time data intelligence. The company uses a collection of AI, ML and NLP tech tools to capture and structure the voice of the patient from real world conversations and behaviours at home. Through mapping thepatient voice from social media and connected devices to regulated medicine information, the company is able to build data points to deliver trends and patterns of patient sentiment across medicines. This intelligence embraces regulatory compliance enabling marketing in pharmaceutical companies to measure patient confidence by medicine and in turn action the levers for share growth.
The North West Fund is a £155m evergreen investment fund established to provide debt and equity funding to small and medium sized enterprises in the North West of England. The Fund will address an identified gap in the lending, venture capital and private equity markets.The Fund is managed by North West Business Finance Limited, an independentprivate sector company.
Show more...Investment focus
- Industry: Health Care, Medical Device, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States
Investor stats
- Total investments: 9
- Round size: Seed $123k–$246k; Series A $737k–$3.8M; Series B $1.2M–$2.5M
- Lead/follow: 22% lead, 78% follow
Portfolio highlights
- Videregen — Videregen’s goal is to offer the world’s first commercially available organ replacement products to address the chronic shortage of organs for transplantation. Formed in 2011 as a spin-out from Northwick Park Institute of Medical Research in London, it uses its proprietary technology to produce biological scaffolds to which a patient’s own stemcells are added, creating a bespoke organ replacement.Initially focused on diseases of the trachea and bowel, Videregen aims to develop the world’s first commercially available organ replacements for these conditions, reducing healthcare costs and improving the quality of life for patients.
- RealityMine — RealityMine enables many of the world’s largest market research and media organisations to monitor real consumers on multiple devices, across all major platforms, revealing unique insights from real life consumer behaviour. The firm’s RealityMeter can be deployed across Android, iOS and desktop platforms, and is deployed by leading panel owners andresearch clients across five continents. RealityMine is headquartered in Manchester, England, with offices in London and Sydney.
- Perfectus Biomed — Perfectus Biomed are leaders in standard & customized microbiology testing services for a variety of sectors, including wound care, medical devices & biocides
MEIF is an investment firm that operates equity and debt investment towards growth capital. The firm aims to transform the finance landscape for smaller businesses in the Midlands and to realize the region’s potential to achieve economic growth through enterprise. It is a collaboration between the British Business Bank and ten Local EnterprisePartnerships (LEPs) in the West Midlands and East and South East Midlands. MEIF provides over £250m of investment to boost small and medium business (SME) growth in the Midlands.
Show more...Investment focus
- Industry: Health Care, Manufacturing, Software
- Stage:Debt Financing, Seed
- Geography: United Kingdom, United States, Thailand
Investor stats
- Total investments: 92
- Round size: Seed $246k–$1.8M; Debt Financing $246k–$1.1M
- Lead/follow: 80% lead, 20% follow
Portfolio highlights
- Capri Healthcare Ltd — Capri Healthcare is an organization driven by the vision of turning NHS Digital first strategy into reality by bringing digital innovation into the working of GP Practices. We lead healthcare organisations into the Digital Era by redesigning and developing patient centric online channels, reducing the NHS burden. We pride ourselves in offering arange of technology-driven innovative solutions to the healthcare industry driving your digital agenda.
- Medmin Group Limited — Medmin is building a group of healthcare businesses that will transform private medical treatment for the uninsured and the clinicians that treat them. We are developing a network of clinics across the UK, grouping clinicians together into branded, condition focussed clinics that patients can easily identify online. The clinics will provide care toour "Get Well Soon" patients and also undertake work for insured and self-pay patients requiring other procedures and treatments.
- School of Coding — School of Coding, We teach coding through our after-school clubs and at our education Centre. We teach coding to children from the age of 6
We provide venture capital investment for the people, ideas and industries that will change the world. Learn about what we do and the kind of founders we back.
Show more...Investment focus
- Industry: Software, Health Care, FinTech
- Stage:Series A, Seed, Series B
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 267
- Round size: Seed $1.2M–$6.1M; Series A $2.5M–$15M; Series B $5.9M–$45M
- Lead/follow: 59% lead, 41% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- AgileRL — AgileRL is revolutionising machine learning with RLOps: MLOps for reinforcement learning. Develop faster and achieve greater performance with the best RL tools.
- Correcto. — Correcto identifies every grammatical error written, ensuring everything you write comes across the way you intend, creating peace of mind to consumers and businesses.
- Bea Fertility — Bea Fertility is a monthly subscription program that provides users with at-home fertility treatment and ovulation tracking.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!BGF invests in hundreds of businesses from an evergreen balance sheet. But we offer more than just growth capital. Find out what makes us different.
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Series A, Private Equity
- Geography: United Kingdom, Ireland, United States
Investor stats
- Total investments: 220
- Round size: Series A $1.2M–$16M; Private Equity $5.4M–$28M
- Lead/follow: 85% lead, 15% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Avoca Clinic — The Avoca Clinic is Ireland's only plastic surgery clinic. Our World Class Consultants are all Irish Medical Council Registered. Book a free consultation today
- Stellar Omada — Stellar Omada delivers leading business & digital transformation that exceeds expectations in a constantly changing world. Contact us.
- Machine Discovery — Machine Discovery is a University of Oxford spin-out commercializing new machine learning technology. We leverage proprietary neural network technology to accelerate expensive calculations — and we do it with minimal data and 99.9% fidelity.
Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Series A, Seed
- Geography: United Kingdom, United States
Investor stats
- Total investments: 74
- Round size: Seed $369k–$2.7M; Series A $1.2M–$11M
- Lead/follow: 66% lead, 34% follow
- Last fund: May invest from a new fund soon — raised $33M in 2018
Portfolio highlights
- Camena Bioscience — Camena Bioscience is a synthetic biology company that develops tools to engineer new synthetic biology applications. It has engineered new nucleic acid synthesis technology which improves the quality and speed of synthesis. Its multi-enzymatic technology takes one approach to DNA, RNA, and XNA synthesis, offering increased accuracy over existingPhosphoramidite synthesis technology.Camena Bioscience was founded in 2016 and is headquartered in Cambridge.
- Nova Pangaea Technologies (NPT) — NPT is a cleantech company that has developed a revolutionary process technology called REFNOVA. REFNOVA allows customers to converts non-food plant residues into sustainable products such as biochar, activated carbon, biofuel, biopolymers and biochemicals. Our products help customers replace fossil based products and enable decarbonisation.
- Send — We're transforming commercial insurance software with our composable SaaS platform, which seamlessly scales and flexes to cover everything your team needs.
Volution is a UK based Venture Capital firm. We back ambitious Fintech and SaaS businesses, ready to accelerate their growth to Series B and beyond.
Show more...Investment focus
- Industry: Health Care, Software, Medical
- Stage:Series A, Seed
- Geography: United Kingdom, United States
Investor stats
- Total investments: 48
- Round size: Seed $522k–$1.2M; Series A $603k–$6.1M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- Zopa — Zopa is a P2P money lending service that allows lenders and borrowers to deal directly with one another, cutting out the banks who act as middlemen. It works in the following way: the company first categorizes borrower credit grades with an A*, A, B, C, or Y rating; then lenders make offers that vary by money amount and time period for persons witha certain credit grade, and borrowers can then agree the aggregate offered rate.Zopa takes on such responsibilities as distributing money between parties, completing the legal paperwork, performing borrower identity/credit checks, and employing a collections agency that chases missed payments for the lender.Zopa also mitigates risk for lenders by enforcing monthly direct debit repayment, making borrowers sign a legal contract, and allowing lenders to lend small chunks of money to individual borrowers (i.e. someone lending £1000 would have their money spread across say, 100 borrowers).The company itself makes money by charging a fixed fee for borrowers and a 1% annual fee for lenders.Zopa has received public acclaim as well, having been awarded CNET Technology Awards' 2006 Internet Innovation of the Year, the 2007 Webby Award for Best Banking/Bill-Paying Website, the 2008 Webby Award for Financial Services, the Banker 2007 Award for Best Internet Project, and Moneywise 2009 Awards for Best Customer Service and Best Personal Loan.One of the three initial members of the UK's Peer-to-Peer Finance Association, together with FundingCircle and RateSetter. Other P2P lending services include
- DeadHappy — Life's too short to shop around for life insurance. Say hello to DeadHappy, a brand new type of life insurance that's quick, easy and flexible.
- Lightpoint Medical — Lightpoint is developing miniaturized imaging and sensing tools for advanced robot-assisted cancer surgery.
Oxford Sciences Innovation is the world’s largest university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companiestaking on challenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A
- Geography: United Kingdom, United States, The Netherlands
Investor stats
- Total investments: 123
- Round size: Seed $1M–$6.8M; Series A $3.7M–$34M
- Lead/follow: 41% lead, 59% follow
Portfolio highlights
- Navenio — Navenio is a software technology company that provides location-based services for indoor environments via mobile applications. Its solution provides an improvement on other indoor localization technologies, having the ability to locate people without the need for implementing, managing, or surveying any new building hardware such as beacons orwi-fi. Navenio’s intelligent workforce solution unlocks significant improvements in the efficiency and workflow of staff and teams through automation that is carefully driven from real-world best practice.The company was founded in 2015 and is headquartered in Oxford, England.
- AlveoGene — Welcome to AlveoGene Transforming Rare Respiratory Disease Outcomes Using Inhaled Gene Therapy More information
- Sitryx Therapeutics — Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation. The company was co-founded by a team of world-leading scientists from the United States and Europe who have contributed significantly to the field of immunometabolism.Sitryx was founded in 2018 with seed funding from SV Health Investors and raised $30 million Series A funding from an international syndicate of specialist investors including SV Health Investors, Sofinnova Partners, Longwood Fund and GSK. The company has a pipeline of projects at multiple stages of drug discovery. Sitryx is headquartered in Oxford, UK.
Southern Angel Investors Club, combining Surrey investors Club & Angels 5K, are entrepreneurs who understand what new businesses need.
Show more...Investment focus
- Industry: Biotechnology, Software, Medical
- Stage:Seed, Angel
- Geography: United Kingdom
Investor stats
- Total investments: 26
- Round size: Seed $74k–$1.2M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Celixir — Celixir is a developer of regenerative medicines created to change the lives of patients in need. The company's medicines consists of iMP cells, platelet lysate and PML cells to treat patients with ischaemic heart disease, injured tendons near the surface of the skin and mild to moderate heart failure respectively, enabling medical researchersto discover breakthrough medicines that aim to change the standard of medical care for patients.
- Novastone Media Ltd. — With its unique asymmetric technology, novastone puts you directly where your clients want to talk to you.
- Geektastic — Geektastic guarantees hiring teams only meet high calibre candidates. Our technical code challenges quickly identify the most talented software engineers.
FSE C.I.C. is an independent not-for-profit Community Interest Company (C.I.C.) whose surpluses are reinvested in the business, rather than being driven by the need to maximise profit for shareholders and owners. FSE C.I.C. has a number of subsidiary companies to deliver its funds and services, which are collectively referred to as The FSE Group.All regulated activities are delivered through FSE Fund Managers Limited, which is authorised and regulated by the Financial Conduct Authority. Finance East Limited delivers funding for businesses based in the East of England region.
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Debt Financing, Seed
- Geography: United Kingdom, United States, Canada
Investor stats
- Total investments: 133
- Round size: Seed $307k–$1.8M; Debt Financing $61k–$430k
- Lead/follow: 77% lead, 23% follow
- Last fund: May invest from a new fund soon — last raise in 2014
Portfolio highlights
- Seriously Low Carb — Award Winning. Consumer brand of choice. Real food that's Keto and Low Carb friendly. The home of the Seriously Low Carb Loaf, the Seriously Low Carb Pizza and now lots of other products too.
- Laserthrust — Laserthrust is developing and producing a 3D-printed, super-cavitating electric craft capable of traveling from Norwich, UK, to Amsterdam. The company's marine goods are made completely of recycled and recyclable FDM 3D-printed materials, with a particular emphasis on TPU-based materials.
- Luxury Cottages — Find a luxury holiday cottage to rent in the UK. Our handpicked holiday homes at Luxury Cottages are carefully selected by our luxury travel experts.
Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Pre-Seed, Seed, Series A
- Geography: Singapore, United Kingdom, Australia
Investor stats
- Total investments: 354
- Round size: Seed $510k–$7.5M; Pre-Seed $100k–$1M; Series A $600k–$29M
- Lead/follow: 55% lead, 45% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Immibot — Get assistance from our AI-powered chatbot on your immigration journey. Our model is trained on official regulations to answer any questions you may have on how to move abroad.
- Quench.ai — Quench is a tech infrastructure for video creators to deliver exclusive content, engage and reward their true fans.
- Source — Source is an AI-powered recruitment platform that makes tech talent sourcing fast, precise, and cost-effective.
EMV Capital is a VC investor specialising in early-stage deep tech B2B companies in the life science, sustainability and industrials sectors.
Show more...Investment focus
- Industry: Health Care, Medical, Manufacturing
- Stage:Seed, Series A
- Geography: United Kingdom, United States, Israel
Investor stats
- Total investments: 25
- Round size: Seed $614k–$3.6M; Series A $3.7M–$5M
- Lead/follow: 80% lead, 20% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- DName-iT — DName-iT is a genetic analysis tool that offers DNA-based barcode labeling technology and a software platform that can ensure reliable, cost-effective NGS specimen identification.
- Vortex Biosciences — Vortex Biosciences provides an easy-to-use, label-free, without sample preparation, benchtop solution for routine isolation and purification of CTCs from your liquid biopsy samples
- Sofant Technologies — Sofant is developing a low cost RF MEMS technology that solves power consumption and heat problems in high frequency phased array antenna systems.
Our primary focus is on the development of novel therapeutics and platforms. We balance the therapeutic focus with investments in medical devices, diagnostics or drug delivery systems. In our investments we look for unmet need and clinical impact, novel proprietary science and understanding of mechanism, management and board experience and capitalefficiency in the program.We prefer to have our initial investment at the early stage to build the company and follow with additional investment in pace with the company:tm:s progress. We continue our approach of larger focused investments and anticipate total investments up to USD 30 to 50 mio per company over its life, but it can be as little as 100'000 USD to get started. We will increase our activities to lead or co-lead deals further and remain open to participate in larger syndicates. SectorsNew therapeutics & platformsMedical devices/implantsDiagnostics/biomarkersDrug delivery/biopolymersGeographyUSA/CanadaEuropeSwitzerlandAsia/Pacific
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series A, Series C
- Geography: United States, Switzerland, United Kingdom
Investor stats
- Total investments: 180
- Round size: Series A $5.1M–$63M; Series B $10M–$80M; Series C $4.8M–$57M
- Lead/follow: 23% lead, 77% follow
- Last fund: May invest from a new fund soon — last raise in 2009
Portfolio highlights
- Oculis — The Oculis drug delivery platform consists of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug delivery system where diseases of the posterior part of the eye can be treated with a simple topical application. The Oculis drug delivery platform allows diseases such as DME(diabetic macular edema) at the posterior part of the eye to be treated with a non-invasive topical application. Furthermore, the technique has been demonstrated to allow diseases at the anterior part of the eye to be treated with a reduced number of topical applications compared to conventional eye-drops.
- CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
- Mediar Therapeutics — Mediar Therapeutics is a preclinical stage biotechnology company developing antibody-based therapeutics to halt fibrosis in a variety of organ systems, including lung, liver, kidney, and skin.
Learn about Invesco through our latest stories, financials, and news.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Series B, Series C
- Geography: United States, United Kingdom, China
Investor stats
- Total investments: 49
- Round size: Series B $3M–$30M; Series C $13M–$195M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Capchase — Capchase is a fintech company that provides financial solutions to startups by allowing access to funds as they grow.
- Brii Biosciences — Brii Biosciences is a developer of bio-pharmaceutical medicines intended to provide medical solutions to Chinese patients to fulfill their health and treatment needs. The company's medicines focuses on infectious disease drug development and commercialization in China and leverage technology and data to drive improvements to the Chinesehealthcare system and outcomes for patients, enabling patients to get access to better treatments and cures for life-threatening diseases.
- WT Microtech Medical — WT Microtech Medical mainly engaged in the R&D, production, sales and maintenance of the third category of medical devices.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Helping individuals and institutions invest in Venture Capital, Infrastructure and Media companies since 1999.
Show more...Investment focus
- Industry: Software, Mobile, Health Care
- Stage:Seed, Series A
- Geography: United Kingdom, United States, France
Investor stats
- Total investments: 133
- Round size: Seed $1.6M–$3.6M; Series A $1.6M–$13M
- Lead/follow: 28% lead, 72% follow
- Last fund: May invest from a new fund soon — last raise in 2015
Portfolio highlights
- Scan.com — Use scan.com to find the best medical imaging centers near you Find an MRI scan, CT scan, X-ray Scan, or other diagnostic imaging scan with scan.com.
- HelloSelf — The UK's Trusted Online Private Clinical Therapy Service
- Legislate — Legislate is an easy-to-use contract management platform which provides a suite of customisable contracts for businesses and landlords.
SR One Capital Management is a leading trans-Atlantic biotech venture capital firm that partners with top entrepreneurs, scientists and investment partners to seek to build elite biotechnology companies. Our mission is to translate ground-breaking technologies into next generation medicines to benef
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 154
- Round size: Series A $3.7M–$40M; Series B $15M–$85M; Series C $27M–$57M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Fore Biotherapeutics — We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
- Avalyn Pharma — This does NOT display on the home page
- Nimbus Therapeutics — Nimbus Discovery is now Nimbus Therapeutics to reflect our transition into a clinical stage company. Nimbus Therapeutics is a biotechnology company headquartered in Cambridge, Mass., that is pioneering a new computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinicaldevelopment. We are designing highly selective and potent medicines to disrupt known drivers of serious diseases, including metabolic disease, cancer and immune-inflammatory disorders.
Mercia Equity Finance is a regional investor that focuses initially on uncovering the hidden value. It uses both of its managed funds and its proprietary capital to invest across four distinct asset classes: venture, private equity, and debt, referred to as their 'Complete Capital Solution’. It aspires to be the first choice for investors,investees, and employees, and, by aspiring to be the first choice, they believe that Mercia will deliver superior returns for business owners, shareholders, and fund investors alike.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: United Kingdom
Investor stats
- Total investments: 62
- Round size: Seed $307k–$2.7M; Series A $922k–$6.1M
- Lead/follow: 71% lead, 29% follow
Portfolio highlights
- Envoke — The engagement Platform for your Virtual Instrument.
- Invincibles Studio — We're an independent games studio, making exceptional football games for mobile devices that have been downloaded over 50 million times.
- Productive Machines — We create digital twins of the milling process to identify vibrations and then automatically personalize the tool path parameters to eliminate chatter. Our customers get to the best part, faster, the first time.
Founded in 2008, Par Equity is a venture capital firm that backs the most innovative, high growth technology companies in the North of the UK. Based in Edinburgh, Par invests across Northern England, Northern Ireland and Scotland.
Show more...Investment focus
- Industry: Software, Information Technology, Computer
- Stage:Seed, Series A
- Geography: United Kingdom, United States, Brazil
Investor stats
- Total investments: 163
- Round size: Seed $244k–$4.7M; Series A $1.6M–$7.9M
- Lead/follow: 56% lead, 44% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- Plotbox — Award winning Cemetery and Crematory management software that enables world class death care facility operations. Fully integrated software and true digital mapping solve long standing problems and accelerates business development. Various packages available.
- Partful — Make sure customers get the right parts first time, every time with digital 3D parts catalogue software and digital work instructions.
- Manus Neurodynamica — Manus Neurodynamica is a triage device to support early diagnostics in Parkinson's disease.
Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.
Show more...Investment focus
- Industry: Health Care, Software, SaaS
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 17
- Round size: Seed $823k–$2.9M
- Lead/follow: 41% lead, 59% follow
- Last fund: May invest from a new fund soon — last raise in 2011
Portfolio highlights
- Cloud8 — At Cloud8 It provide an intuitive cloud platform to corporate advisors. It improving the employee experience through affordable digital benefits, excellent support, reporting and communications – something which has previously been out of reach for SME clients.
- Citizenme — Real people. Deeper insights. Better business. The only fully-functional zero-party data platform. Built by experts. Powered by citizens.
- Sense Biodetection — Sense Biodetection Limited is a molecular diagnostics company focused on improving healthcare decisions and processes by developing novel, user-centred, handheld tests in the fields of infections and oncology.
Equity Gap is a group of private individuals set up to invest in and support emerging and growing businesses based in Scotland
Show more...Investment focus
- Industry: Information Technology, Software, SaaS
- Stage:Seed, Series A
- Geography: United Kingdom
Investor stats
- Total investments: 88
- Round size: Seed $307k–$2.9M; Series A $2.7M–$9.2M
- Lead/follow: 53% lead, 47% follow
Portfolio highlights
- Shot Scope — The official Shot Scope website. Golf watches, range finders and performance tracking that help lower your score and handicap. Buy direct online today!
- PneumoWave — Empowering Intervention and Prevention for Opioid-Induced Respiratory Depression
- Vector Photonics — Vector Photonics is a spin-out company from the University of Glasgow and is based in Glasgow, Scotland, one of the UK and world’s Optical and Photonics centres of excellence.
Wren is an angel investor in science, engineering and software. They founded Wren in 2011 and have invested in 50 companies so far.Wren is well known in the early stage investment community and has co-invested with a wide range of both angel and institutional investors. From software and semiconductors to genome editing, and from medical devicesto satellites, they are interested in sectors where technical ingenuity and hard work can produce long term value. They look for people with a deep understanding of their markets. The founders they invest in are smart and they get things done.Wren typically invests £50,000 to £200,000 per funding round. Difficult problems take time to solve, so they are patient with their investments. Their aim is to get deals done and they take a pragmatic approach to doing so.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A
- Geography: United Kingdom
Investor stats
- Total investments: 22
- Round size: Seed $1.5M–$3M; Series A $2.1M–$19M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- PharmEnable — Designing the next generation of small molecule drugs. Replicating the specificity of biologics in the scalable form of a small molecule.
- MitoRx Therapeutics — Developing revolutionary mitochondrial-protective therapeutics which reverse mitochondrial dysfunction to arrest decline in muscular dystrophy and neurodegeneration. MitoRx Therapeutics' first-in-class first-in-target platform has potential to arrest the progression of some of the most challenging diseases.
- Bastion Therapeutics — Bastion Therapeutics - Enhancing Tregs To Restore Balance In Inflammatory Disorders Treg cell therapy for inflammatory disorders and autoimmune diseases.
UK's leading investment service for high net worth and sophisticated investors. Tax-efficient investments, free guides, and exclusive investment opportunities.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 21
- Round size: Seed $1.2M–$5.5M; Series A $1.8M–$3.7M
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- Fabacus — We are a leading data and technology business with a unique data service designed to digitally-transform the licensing industry. Contact us today.
- SolasCure — Our proprietary technology leverages biomimicry and evidence-based medicine to treat patients with chronic wounds.
- Filament AI — We're experts in applied AI. We help organisations leverage AI and Machine Learning technologies. We are dedicated to growing our clients' AI capability.
The Cambridge Angels are a group of high-net worth investors who have proven experience as successful entrepreneurs in internet, software, technology and bio-technology. Members invest in and mentor high quality start-up and early-stage companies in these sectors in the Cambridge (UK) area and throughout the UK.Typical funding requirements thatthe Cambridge Angels meet are in the range of £50,000 to £500,000 - although it is worth noting that several of their portfolio companies have received more than £1m in funding from their Members over several funding rounds.Their Members have been responsible for a large number of the “Cambridge Phenomenon” success stories over recent years. Therefore, in addition to providing funding for early-stage companies, the Cambridge Angels also offer start-ups the considerable benefit of a wide range of expertise, contacts and directly relevant experience in establishing and growing entrepreneurial businesses successfully.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A
- Geography: United Kingdom, United States, Estonia
Investor stats
- Total investments: 116
- Round size: Seed $244k–$2.5M; Series A $983k–$16M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Molymem — Molymem enhances the performance of filtering membranes used in separation processes including desalination and the removal of industrial contaminants.
- Silveray — Silveray develop affordable large-area direct conversion detectors for the X-ray imaging market.
- Five Alarm Bio — Five Alarm Bio is a drug discovery company. Five Alarm intends to use discoveries to provide secure and efficient remedies for a variety of age-related illnesses and limitations. Five Alarm Bio is creating a small molecule strategy to strengthen the body's defense against aging.
The GM&C Life Sciences Fund is a seed and early stage venture capital fund targeting life sciences businesses located in the Greater Manchester and Cheshire & Warrington region. The Fund is managed by Catapult Venture Managers ("Catapult Ventures").The Fund is based at Alderley Park, which is well recognised as a site ofnational importance, being the largest life sciences campus of its kind in the UK with more than 500,000 sq. ft. of top-end laboratory and related space and facilities. Until recently, the Park was the R&D headquarters for AstraZeneca.Since 2002, Catapult Ventures has backed a significant number of companies across a broad range of life sciences, including therapeutics (such as Abzena and Oxford BioTherapeutics), medical devices (such as Monica Healthcare and Probe Scientific), contract research organisations (such as R5 Pharmaceuticals and FDAS), diagnostics developers (such as Lumora and Biofortuna), as well as developers of technology used in healthcare applications (such as Oxford Cryosystems and Accutronics). The Fund is the result of a collaboration between Cheshire and Warrington Enterprise Partnership, Greater Manchester Combined Authority, Cheshire East Council, and Manchester Science Partnerships.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: United Kingdom, Italy, Germany
Investor stats
- Total investments: 32
- Round size: Seed $61k–$903k
- Lead/follow: 69% lead, 31% follow
Portfolio highlights
- ScubaTx — ScubaTx is a breakthrough organ preservation device organ transplant. The ScubaTx device will leverage world-leading expertise in software design to commercialise a proven but unexploited organ preservation technique, Persufflation. ScubaTx will offer healthcare providers significant net savings, an
- Flynotes — Flynotes is a digital software platform helping dentists deliver personalised patient care
- QV Bioelectronics — Manchester-based start-up QV Bioelectronics is developing innovative electrotherapy devices for the treatment of certain types of brain tumours.
Medical Device VC funding in United Kingdom at a glance
Stats across 552 deals from 472 investors.
Access all 472 VC funds in United Kingdom Medical Device startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Device VC Funds in United Kingdom investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 472 VC funds investing in United Kingdom Medical Device startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!